Nasdaq · Biotech stocks database

KMDA — Kamada Ltd.

KMDA (Kamada Ltd.) stock: $8.85, $510.7M market cap, $75.5M cash, $435.2M EV, $542.0M fully diluted market cap. Data from Fully Diluted's biotech stocks database.

Share price

$8.85

Market cap

$510.7M

Cash

$75.5M

Enterprise value

$435.2M

Balance sheet

Cash	$75.5M
Debt	$0.0M
Net cash	$75.5M
Enterprise value	$435.2M
Basic shares	57.7M shares
Fully diluted shares	61.2M shares
Fully diluted market cap	$542.0M
Cash per share	$1.31

Cash figures as of 2025-12-31. Database snapshot: 2026-09-21.

Price history

Loading KMDA daily closes…

Loading price history…

Active clinical trials

Trial	Phase	Status	Role	Sponsor	BP	Condition(s)	Mgmt guide
NCT07009548	Not disclosed	Enrolling by invitation	Collaborator	Fernanda P Silveira, MD, MS	—	Cytomegalovirus (CMV) Infection	—
NCT06958796	Not disclosed	Recruiting	Collaborator	Camille N. Kotton, MD	—	Cytomegalovirus; Organ Transplant; Kidney Transplant; Complications	—

Sponsor-matched active trials from ClinicalTrials.gov (0 as sponsor, 2 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.

View all 2 active trials for Fernanda P Silveira, MD, MS on ClinicalTrials.gov

Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 714 stocks.

Subscribe to Compounding Ego